Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
56.77 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 213.584 | 132.944 | 307.584 | 713.526 | 433.584 | 113.432 | 100.488 | 161.12 | 93.569 | 24.324 | 7.427 | 86.19 | 10.645 |
| Short Term Investments
| 363.625 | 614.818 | 432.612 | 488.007 | 321.646 | 346.274 | 134.005 | 219.028 | 343.428 | 163.163 | 45.95 | 0 | 0 |
| Cash and Short Term Investments
| 777.11 | 896.732 | 999.129 | 1,212.039 | 760.404 | 459.706 | 244.468 | 498.111 | 436.997 | 187.487 | 53.377 | 86.19 | 10.645 |
| Net Receivables
| 73.39 | 40.445 | 28.432 | 23.093 | 32.844 | 12.74 | 5.172 | 0 | 0 | 0 | 0 | 0 | 0.103 |
| Inventory
| 33.969 | 26.766 | 16.231 | 13.048 | 11.546 | 7.065 | 0.757 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| -777.11 | 68.926 | -187.188 | 47.124 | 46.223 | 42.858 | 29.161 | 21.547 | 13.21 | 5.929 | 1.848 | 0.255 | 0.205 |
| Total Current Assets
| 732.184 | 883.899 | 856.604 | 1,295.304 | 851.017 | 522.369 | 244.468 | 498.111 | 450.207 | 187.487 | 55.225 | 86.445 | 10.953 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 290.566 | 285.687 | 176.183 | 114.039 | 74.676 | 20.046 | 21.837 | 17.055 | 7.373 | 3.033 | 1.325 | 1.362 | 0.759 |
| Goodwill
| 44.406 | 44.406 | 44.406 | 44.406 | 44.406 | 44.406 | 44.406 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 166.271 | 160.105 | 130.788 | 131.113 | 129 | 129.223 | 141.545 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 210.677 | 204.511 | 175.194 | 175.519 | 173.406 | 173.629 | 185.951 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 199.901 | 154.501 | 293.858 | 165.881 | 32.926 | 1.822 | 9.975 | 117.963 | 99.259 | 0 | 0 | 0 | 0 |
| Tax Assets
| 5.959 | 6.143 | 8.941 | 33.348 | 7.662 | -1.822 | 25.115 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 51.726 | 10.703 | 11.617 | -24.536 | -4.191 | 3.514 | 3.407 | -92.503 | 2.73 | 7.447 | 3.099 | 0.509 | 0.417 |
| Total Non-Current Assets
| 758.829 | 661.545 | 665.793 | 464.251 | 284.479 | 197.189 | 246.285 | 42.515 | 109.362 | 10.48 | 4.424 | 1.871 | 1.176 |
| Total Assets
| 1,491.013 | 1,545.444 | 1,522.397 | 1,759.555 | 1,135.496 | 719.558 | 490.753 | 540.626 | 559.569 | 197.967 | 59.649 | 88.316 | 12.129 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 42.114 | 43.274 | 17.138 | 12.923 | 12.871 | 12.275 | 8.886 | 5.364 | 2.942 | 4.857 | 1.437 | 1.2 | 0.342 |
| Short Term Debt
| 12.595 | 11.779 | 11.066 | 8.976 | 7.235 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 196.486 | 1.479 | 7.609 | 59.219 | 0 | 0 | 5.986 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 29.242 | 204.678 | 145.555 | 108.491 | 83.194 | 62.45 | 56.142 | 54.895 | 24.976 | 7.66 | 4.484 | 1.988 | 0.657 |
| Total Current Liabilities
| 280.437 | 261.21 | 181.368 | 189.609 | 103.3 | 74.725 | 71.014 | 60.259 | 27.918 | 12.517 | 5.921 | 3.188 | 0.999 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 30.574 | 19.814 | 30.904 | 39.251 | 29.757 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 862.325 | 0 | 1.467 | 7.349 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 30.058 | 31.667 | 33.306 | 33.306 | 33.306 | 31.166 | 31.166 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 12.205 | 880.259 | 352.791 | 335.665 | 315.369 | 4.759 | 5.119 | 6.393 | 0.561 | 0.505 | 3.619 | 0.788 | 0.487 |
| Total Non-Current Liabilities
| 935.162 | 931.74 | 418.468 | 415.571 | 378.432 | 35.925 | 36.285 | 6.393 | 0.561 | 0.505 | 3.619 | 0.788 | 0.487 |
| Total Liabilities
| 1,215.599 | 1,192.95 | 599.836 | 605.18 | 481.732 | 110.65 | 107.299 | 66.652 | 28.479 | 13.022 | 9.54 | 3.976 | 1.486 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.095 | 0 | 197.967 | 124.93 | 111.387 | 18.604 |
| Common Stock
| 0.082 | 0.07 | 0.069 | 0.067 | 0.058 | 0.051 | 0.044 | 0.041 | 0.039 | 0.032 | 0.004 | 0.003 | 0.003 |
| Retained Earnings
| -3,387.661 | -2,781.022 | -2,073.601 | -1,619.576 | -1,433.01 | -1,030.283 | -832.672 | -530.533 | -284.659 | -139.041 | -74.836 | -27.058 | -8.155 |
| Accumulated Other Comprehensive Income/Loss
| 0.647 | -6.573 | -1.404 | 0.689 | -0.147 | -0.633 | -5.68 | 0.905 | -0.868 | -0.174 | 0.011 | -0.353 | -0.04 |
| Other Total Stockholders Equity
| 3,662.346 | 3,140.019 | 2,997.497 | 2,773.195 | 2,086.863 | 1,639.773 | 1,221.762 | 1,003.466 | 816.578 | 126.161 | 0 | 0.361 | 0.231 |
| Total Shareholders Equity
| 275.414 | 352.494 | 922.561 | 1,154.375 | 653.764 | 608.908 | 383.454 | 473.974 | 531.09 | 184.945 | 50.109 | 84.34 | 10.643 |
| Total Equity
| 275.414 | 352.494 | 922.561 | 1,154.375 | 653.764 | 608.908 | 383.454 | 473.974 | 531.09 | 184.945 | 50.109 | 84.34 | 10.643 |
| Total Liabilities & Shareholders Equity
| 1,491.013 | 1,545.444 | 1,522.397 | 1,759.555 | 1,135.496 | 719.558 | 490.753 | 540.626 | 559.569 | 197.967 | 59.649 | 88.316 | 12.129 |